Related Experiment Videos
Drug-induced q-T prolongation
1Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN 46206, USA. lkao@clarian.org
The Medical Clinics of North America
|October 18, 2005
Summary
Certain medications can prolong the Q-T interval, increasing the risk of Torsade de Pointes (TdP) and sudden cardiac death. Clinicians must carefully assess patient and drug factors to mitigate these risks.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Drug-induced Q-T prolongation affects cardiac repolarization via potassium ion channel alterations.
- This condition is linked to Torsade de Pointes (TdP), a potentially fatal ventricular arrhythmia.
- Recent regulatory actions highlight the clinical significance of Q-T prolongation.
Purpose of the Study:
- To review the mechanisms and risk factors associated with drug-induced Q-T prolongation.
- To emphasize the clinical implications of Q-T prolongation and TdP.
- To guide clinicians in managing medication risks related to Q-T interval.
Main Methods:
- Review of existing literature on drug-induced Q-T prolongation.
- Analysis of the pathophysiology of cardiac repolarization abnormalities.
- Examination of patient-specific and medication-related risk factors.
Main Results:
- Drug therapy can alter cardiac potassium currents, leading to Q-T prolongation.
- Both congenital and acquired Q-T prolongation increase the risk of TdP.
- Individual risk is influenced by a combination of patient and medication factors.
Conclusions:
- Clinicians must be vigilant about prescribing drugs that may prolong the Q-T interval.
- Careful risk-benefit assessment is crucial when using medications known to affect Q-T duration.
- Awareness of drug-induced Q-T prolongation is essential for preventing adverse cardiac events.